Marvel End Period Cash Flow from 2010 to 2024
| MRVL Stock | 0.17 0.01 5.56% |
End Period Cash Flow | First Reported 2010-12-31 | Previous Quarter 640.1 K | Current Value 829 K | Quarterly Volatility 638.5 K |
Check Marvel Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Marvel Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 41.8 K, Interest Income of 0.0 or Selling General Administrative of 1.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Marvel financial statements analysis is a perfect complement when working with Marvel Biosciences Valuation or Volatility modules.
Marvel | End Period Cash Flow |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Marvel Stock Analysis
When running Marvel Biosciences' price analysis, check to measure Marvel Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marvel Biosciences is operating at the current time. Most of Marvel Biosciences' value examination focuses on studying past and present price action to predict the probability of Marvel Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marvel Biosciences' price. Additionally, you may evaluate how the addition of Marvel Biosciences to your portfolios can decrease your overall portfolio volatility.